A pt comes with stage III non seminomatous testicular tumor t/t of choice is :
Stage III means the cancer has spread to distant lymph nodes or other organs. For NSGCT, the initial treatment is usually chemotherapy because it's more effective than radiation. The options for stage III might involve a combination of surgery and chemotherapy. Let me think about the specific regimens. The standard chemotherapy for NSGCT is cisplatin-based, like the BEP regimen (bleomycin, etoposide, cisplatin). But wait, sometimes they might use carboplatin instead, like the EP regimen.
Wait, the question is about the treatment of choice. For stage III NSGCT, the primary treatment is chemotherapy, often with BEP or VIP (etoposide, ifosfamide, cisplatin). After chemotherapy, if there's residual mass, imaging like CT scan is done, and sometimes retroperitoneal lymph node dissection (RPLND) is performed. But in stage III, the mainstay is chemotherapy first.
Now, looking at the answer options. The correct answer would be chemotherapy. Let me check the options. The user hasn't provided the options, but common distractors might include surgery as first-line, radiation therapy, or maybe some other regimens.
Radiation is not used for NSGCT because these tumors are less responsive compared to seminomas. Surgery, like orchiectomy, is the first step, but the main treatment for stage III is chemotherapy. So the correct answer should be chemotherapy, specifically a regimen like BEP.
So the correct answer is chemotherapy. The options might have listed other treatments, but the key is that chemotherapy is the primary treatment for stage III NSGCT.
**Core Concept**
Non-seminomatous germ cell tumors (NSGCT) are highly chemosensitive. Stage III disease indicates metastasis beyond regional lymph nodes, requiring systemic therapy. Cisplatin-based chemotherapy is the cornerstone of treatment due to its efficacy against NSGCT.
**Why the Correct Answer is Right**
The standard treatment for stage III NSGCT is **cisplatin-based chemotherapy**, typically with the **BEP regimen** (bleomycin, etoposide, cisplatin) for 3β4 cycles. This regimen achieves high cure rates (80β90%) by targeting rapidly dividing germ cells. Chemotherapy is prioritized over surgery because NSGCTs are more chemosensitive than seminomas and often have bulky metastases. Post-chemotherapy, residual masses are evaluated with imaging or biopsy to guide further surgical intervention.
**Why Each Wrong Option is Incorrect**
**Option A:** *Radiation therapy* is incorrect. NSGCTs are resistant to radiation compared to seminomas.
**Option B:** *Retroperitoneal lymph node dissection (RPLND)* is incorrect. While RPLND is used post-chemotherapy for residual disease, it is not first-line.
**Option C:** *Orchiectomy alone* is incorrect. Stage III requires systemic therapy, as localized surgery cannot address metastatic disease.
**Clinical Pearl /